Full Year Net Loss: $63.7 million, compared to $65.8 million in prior year. Aadi Bioscience Inc (NASDAQ:AADI) has successfully transitioned into Whitehawk Therapeutics, focusing on advanced ADC ...
Kaken assumes ownership of Aadi Sub, including the Aadi Bioscience name, trademarks and the FYARRO ® (sirolimus protein-bound particles for injectable suspension) (albumin-bound) business.
Aadi is a precision oncology company with a vision to make bold choices in applying technology to efficiently deliver improved precision oncology therapies for people living with difficult-to ...
Aadi Industries Ltd share price was down by -0.36% from the previous closing price of ₹5.60. Who are peers of Aadi Industries Ltd? The peers of Aadi Industries Ltd are Supreme Industries Ltd ...
The actor - who has played Dev Alahan's son Aadi since 2020 - hasn't had a proper storyline in months. The star has only been making occasional appearances on the cobbles for the past year ...
The Central Bureau of Investigation (CBI) is conducting searches in connection with the Mahadev application case involving former CM Bhupesh Baghel. The probe has revealed the app's involvement in ...
Aadi Industries Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 5.80 Crore) operating in Miscellaneous sector. Aadi Industries Ltd. key Products/Revenue Segments ...
Kaken assumes ownership of Aadi Sub, including the Aadi Bioscience name, trademarks and the FYARRO ® (sirolimus protein-bound particles for injectable suspension) (albumin-bound) business. Whitehawk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results